First, we compared basal mRNA levels of the three HAS isoforms (HAS1, HAS2 and HAS3), CD44 and RHAMM in immortalized BEAS-2B bronchial cells and NSCLC cell lines. This evidence concerns the gene HAS1 and non-small cell lung carcinoma.